Release date: 2017-01-18
In the winter smog season, in addition to air purifiers and masks, the main health care products related to "clear lungs" are also selling well.
Japan’s Kobayashi intends to increase its sales of “Qi lung soup DUSMOCK†by 30% this year to reach 1.1 million bags. It will increase the production of Qingfei Decoction by extending the start-up time of the factory.
This Qingfei soup is the "new bestseller" of Kobayashi. It packs 1,500 yen (about 89.2 yuan) per box in 12 bags. According to the Nikkei News, shipments of this Qingfei soup from April to September 2016 were 430 million yen, an increase of about 40% year-on-year.
“Qingfei Tang DUSMOCK†was launched in September 2014. The initial target population was middle-aged smokers, claiming to use Han Chinese (ie Chinese medicine). With the increase in Chinese consumers traveling to Japan, it began to emphasize the selling point of “smogâ€.
It is worth pointing out that the products such as "Qingfei Decoction DUSMOCK" and other main functions of clearing the lungs are not pharmaceuticals, but "dietary nutritional supplements". If you search for relevant knowledge, you will find that smog is essentially a physical function and cannot be solved by drugs. Therefore, the so-called decoction is to give you immunity to prevent infection. This is a veritable edge ball product.
The product has not officially entered the Chinese market, and consumers can purchase it through purchasing or going to Japan. Lunar New Year is a climax of travel to Japan. Kobayashi is also waiting in the drug store, and has prepared an in-store promotional advertisement with Chinese. The amount of spending on visitors to Japan has become smaller – from high-priced items such as jewelry to daily necessities, Kobayashi expects to increase demand in the future, so it decided to increase production.
As the smog has increased, air purifiers and masks have gradually become a must. The South China Morning Post reported that sales of Dyson air purifiers tripled in 2015. According to Grand View Research, the sales of indoor air purifiers will reach US$21.82 billion by 2024, and the main driving force behind this is China.
The next market outside of the two may be health care products related to lung function. Several New Zealand and Australian health care brands, including Swisse, also have related “clear lung productsâ€. Regarding whether these things have an effect, the right to see how much knowledge you have.
Source: Curiosity Daily
Auto Hematology Analyzer,Clinical Hematology Analyzer,Blood Analyzer Hematology,Hematology Analyzer
Guangdong Widinlsa International Co.Ltd , https://www.widinlsa.com